Thalidomide 4'-ether-alkylC5-acid

Pricing Availability   Qty
Description: Cereblon ligand with alkyl linker and terminal acid for onward chemistry
Chemical Name: 6-[[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]hexanoic acid
Purity: ≥95% (HPLC)
Datasheet
Citations
Reviews
Literature (2)

Biological Activity for Thalidomide 4'-ether-alkylC5-acid

Thalidomide 4'-ether-alkylC5-acid is a functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC5 linker with a terminal carboxylic acid ready for conjugation to a target protein ligand. Part of a range of functionalized tool molecules for PROTAC R&D.

Please contact us for SD files of our available Degrader Building Blocks.

PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

Usage Guidelines for Thalidomide 4'-ether-alkylC5-acid

This product is provided for use in onward chemistry. Suitable solvents can be used.

Technical Data for Thalidomide 4'-ether-alkylC5-acid

M. Wt 388.38
Formula C19H20N2O7
Storage Store at -20°C
Purity ≥95% (HPLC)
CAS Number 2087490-48-8
PubChem ID 132212109
InChI Key PBZGPWVWKSADLD-UHFFFAOYSA-N
Smiles OC(CCCCCOC1=C2C(N(C(C2=CC=C1)=O)C3CCC(NC3=O)=O)=O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Thalidomide 4'-ether-alkylC5-acid

References for Thalidomide 4'-ether-alkylC5-acid

References are publications that support the biological activity of the product.

If you know of a relevant reference for Thalidomide 4'-ether-alkylC5-acid, please let us know.

Keywords: Thalidomide 4'-ether-alkylC5-acid, Thalidomide 4'-ether-alkylC5-acid supplier, functionalized, PROTACs, cereblon, E3, ubiquitin, ligase, alkyl, C5, linker, conjugate, targeted, protein, degradation, TPD, building, blocks, components, Cereblon, Ligands, Plus, Linkers, 7332, Tocris Bioscience

Citations for Thalidomide 4'-ether-alkylC5-acid

Citations are publications that use Tocris products.

Currently there are no citations for Thalidomide 4'-ether-alkylC5-acid. Do you know of a great paper that uses Thalidomide 4'-ether-alkylC5-acid from Tocris? Please let us know.

Reviews for Thalidomide 4'-ether-alkylC5-acid

There are currently no reviews for this product. Be the first to review Thalidomide 4'-ether-alkylC5-acid and earn rewards!

Have you used Thalidomide 4'-ether-alkylC5-acid?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


TPD and Induced Proximity Research Product Guide

TPD and Induced Proximity Research Product Guide

This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:

  • Active Degraders
  • TAG Degradation Platform
  • Degrader Building Blocks
  • Assays for Protein Degradation
  • Induced Proximity Tools
Targeted Protein Degradation Poster

Targeted Protein Degradation Poster

Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia